Skip to main content
. 2018 Nov 2;45(1):37–47. doi: 10.1093/schbul/sby153

Table 3.

Results of Longitudinal Mediation Analyses

Model (all n = 47) Predictor Suicidal ideation in 9- or 18-mo completers
Unstandardized coefficients (SE) Completely standardized coefficients (95% CI)
Overall symptoms Control variables Age (baseline), y 0.010 (0.008)
Gender (fixed) −0.325 (0.170)*
Education (baseline) −0.013 (0.029)
Treatment allocation −0.082 (0.168)
Suicidal ideation at mo 0 0.515 (0.122)***
9- or 18-mo data 0.299 (0.200)
Independent variables Overall symptoms at mo 0 (direct effect) 0.001 (0.007)
Negative cognitive appraisals at mo 0 −0.022 (0.034)
Negative metacognitive beliefs at mo 0 0.043 (0.023)*
R2 0.562***
Bootstrap indirect effects of Overall symptoms > Negative cognitive appraisals −0.001 (0.002)
95% CI (−0.007, 0.001)
−0.022 (−0.049, 0.253)
Overall symptoms > Negative metacognitive beliefs 0.002 (0.003)
95% CI (−0.001, 0.011)
0.038 (−0.029, 0.235)
Overall symptoms > Negative cognitive appraisals > Negative metacognitive beliefs 0.001** (0.001)
95% CI (0.000, 0.006)
0.028** (0.000, 0.120)
Total indirect effect 0.002 (0.003)
95% CI (−0.002, 0.012)
0.045 (−0.049, 0.253)
Positive symptoms Control variables Age (baseline), y 0.010 (0.008)
Gender (fixed) −0.354** (0.167)a
Education (baseline) −0.014 (0.029)
Treatment allocation −0.067 (0.166)
Suicidal ideation at mo 0 0.538*** (0.121)a
9- or 18-mo data 0.308 (0.196)
Independent variables Positive symptoms at mo 0 (direct effect) −0.012 (0.020)
Negative cognitive appraisals at mo 0 −0.020 (0.034)
Negative metacognitive beliefs at mo 0 0.045* (0.023)a
R2 0.566**a
Bootstrap indirect effects of Positive symptoms > Negative cognitive appraisals −0.002 (0.004)
95% CI (−0.017, 0.002)
−0.013 (−0.135, 0.018)
Positive symptoms > Negative metacognitive beliefs 0.005 (0.009)
95% CI (−0.005, 0.032)
0.041 (−0.040, 0.231)
Positive symptoms > Negative cognitive appraisals > Negative metacognitive beliefs 0.002 (0.004)
95% CI (−0.002, 0.014)
0.019 (−0.013, 0.105)
Total indirect effect 0.006 (0.009)
95% CI (−0.017, 0.002)
0.048 (−0.054, 0.236)
Negative symptoms Control variables Age (baseline), y 0.011 (0.007)
Gender (fixed) −0.322* (0.161)a
Education (baseline) −0.005 (0.029)
Treatment allocation −0.125 (0.167)
Suicidal ideation at mo 0 0.522*** (0.115)a
9- or 18-mo data 0.269 (0.194)
Independent variables Negative symptoms at mo 0 (direct effect) 0.022 (0.017)
Negative cognitive appraisals at mo 0 −0.024 (0.033)
Negative metacognitive beliefs at mo 0 0.044* (0.022)a
R2 0.580**a
Bootstrap indirect effects of Negative symptoms > Negative cognitive appraisals −0.001 (0.006)
95% CI (−0.015, 0.002)
−0.009 (−0.118, 0.016)
Negative symptoms > Negative metacognitive beliefs −0.001 (0.006)
95% CI (−0.014, 0.011)
−0.013 (−0.125, 0.079)
Negative symptoms > Negative cognitive appraisals > Negative metacognitive beliefs 0.001 (0.003)
95% CI (−0.002, 0.011)
0.011 (−0.018, 0.016)
Total indirect effect −0.001 (0.006)
95% CI (−0.012, 0.014)
−0.010 (−0.111, 0.105)
General symptoms Control variables Age (baseline), y 0.009 (0.008)
Gender (fixed) −0.347* (0.173)a
Education (baseline) −0.014 (0.029)
Treatment allocation −0.075 (0.166)
Suicidal ideation at mo 0 0.531*** (0.125)a
9- or 18-mo data 0.318 (0.203)
Independent variables General symptoms at mo 0 (direct effect) −0.004 (0.014)
Negative cognitive appraisals at mo 0 −0.020 (0.034)
Negative metacognitive beliefs at mo 0 0.044* (0.023)a
R2 0.562**a
Bootstrap indirect effects of General symptoms > Negative cognitive appraisals −0.002 (0.004)
95% CI (−0.015, 0.003)
−0.025 (−0.171, 0.035)
General symptoms > Negative metacognitive beliefs 0.005 (0.006)
95% CI (−0.001, 0.023)
0.061 (−0.019, 0.248)
General symptoms > Negative cognitive appraisals > Negative metacognitive beliefs 0.003** (0.002)a
95% CI (0.000, 0.013)
0.035** (0.004, 0.141)
Total indirect effect 0.006 (0.007)a
95% CI (−0.031, 0.024)
0.071 (−0.044, 0.279)

Note: Exact P values for completely standardized indirect effects not available. Significance (P < .05) inferred when 95% confidence intervals exclude zero.

aRemained or became significant (P < .05) after entering other symptom groups as covariates.

*P < .1, **P < .05, ***P < .01.All significant results (P < .05) are highlighted in bold.